| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2866906
[patent_doc_number] => 05153173
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-10-06
[patent_title] => 'N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use as immunomodulators and immunoadjuvants'
[patent_app_type] => 1
[patent_app_number] => 7/499586
[patent_app_country] => US
[patent_app_date] => 1990-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3911
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/153/05153173.pdf
[firstpage_image] =>[orig_patent_app_number] => 499586
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/499586 | N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use as immunomodulators and immunoadjuvants | Mar 26, 1990 | Issued |
| 07/491066 | POLYAMINES AND POLYEPTIDES USEFUL AS ANTAGONISTS OF EXCITATORY AMINO ACID NEURO-TRANSMITTERS AND/OR AS BLOCKERS OF CALCIUM CHANNELS | Mar 13, 1990 | Abandoned |
Array
(
[id] => 2781709
[patent_doc_number] => 05130129
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-07-14
[patent_title] => 'Method for enhancing antibody transport through capillary barriers'
[patent_app_type] => 1
[patent_app_number] => 7/488993
[patent_app_country] => US
[patent_app_date] => 1990-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6096
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/130/05130129.pdf
[firstpage_image] =>[orig_patent_app_number] => 488993
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/488993 | Method for enhancing antibody transport through capillary barriers | Mar 5, 1990 | Issued |
Array
(
[id] => 2976728
[patent_doc_number] => 05182369
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-01-26
[patent_title] => 'Method for purifying somatotropin monomers'
[patent_app_type] => 1
[patent_app_number] => 7/486476
[patent_app_country] => US
[patent_app_date] => 1990-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6570
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/182/05182369.pdf
[firstpage_image] =>[orig_patent_app_number] => 486476
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/486476 | Method for purifying somatotropin monomers | Feb 27, 1990 | Issued |
Array
(
[id] => 4006209
[patent_doc_number] => 05859208
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Human basic fibroblast growth factor analog'
[patent_app_type] => 1
[patent_app_number] => 7/459739
[patent_app_country] => US
[patent_app_date] => 1990-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19554
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859208.pdf
[firstpage_image] =>[orig_patent_app_number] => 459739
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/459739 | Human basic fibroblast growth factor analog | Feb 11, 1990 | Issued |
Array
(
[id] => 2908983
[patent_doc_number] => 05216132
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-01
[patent_title] => 'Soluble T-cell antigen receptor chimeric antigens'
[patent_app_type] => 1
[patent_app_number] => 7/463743
[patent_app_country] => US
[patent_app_date] => 1990-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14240
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/216/05216132.pdf
[firstpage_image] =>[orig_patent_app_number] => 463743
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/463743 | Soluble T-cell antigen receptor chimeric antigens | Jan 11, 1990 | Issued |
Array
(
[id] => 2735583
[patent_doc_number] => 05039792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-08-13
[patent_title] => 'Allatostatins which inhibit insect juvenile hormone biosynthesis'
[patent_app_type] => 1
[patent_app_number] => 7/452163
[patent_app_country] => US
[patent_app_date] => 1989-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3088
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/039/05039792.pdf
[firstpage_image] =>[orig_patent_app_number] => 452163
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/452163 | Allatostatins which inhibit insect juvenile hormone biosynthesis | Dec 17, 1989 | Issued |
Array
(
[id] => 2788307
[patent_doc_number] => 05093477
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-03-03
[patent_title] => 'Rapidly cleavable substrate for HIV protease'
[patent_app_type] => 1
[patent_app_number] => 7/449766
[patent_app_country] => US
[patent_app_date] => 1989-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3706
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/093/05093477.pdf
[firstpage_image] =>[orig_patent_app_number] => 449766
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/449766 | Rapidly cleavable substrate for HIV protease | Dec 12, 1989 | Issued |
Array
(
[id] => 2735563
[patent_doc_number] => 05039791
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-08-13
[patent_title] => 'Peptide fragments of tissue plasminogen activator'
[patent_app_type] => 1
[patent_app_number] => 7/432256
[patent_app_country] => US
[patent_app_date] => 1989-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4389
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/039/05039791.pdf
[firstpage_image] =>[orig_patent_app_number] => 432256
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/432256 | Peptide fragments of tissue plasminogen activator | Nov 5, 1989 | Issued |
Array
(
[id] => 2848917
[patent_doc_number] => 05110911
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-05-05
[patent_title] => 'Human tumor-associated Thomsen-Friedenreich antigen'
[patent_app_type] => 1
[patent_app_number] => 7/430357
[patent_app_country] => US
[patent_app_date] => 1989-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9198
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/110/05110911.pdf
[firstpage_image] =>[orig_patent_app_number] => 430357
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/430357 | Human tumor-associated Thomsen-Friedenreich antigen | Nov 1, 1989 | Issued |
| 07/421444 | ERYTHROPOIETIN ISOFORMS | Oct 12, 1989 | Abandoned |
Array
(
[id] => 2816552
[patent_doc_number] => 05122596
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-06-16
[patent_title] => 'Polypeptides useful as blockers of calcium channels'
[patent_app_type] => 1
[patent_app_number] => 7/415139
[patent_app_country] => US
[patent_app_date] => 1989-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3450
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/122/05122596.pdf
[firstpage_image] =>[orig_patent_app_number] => 415139
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/415139 | Polypeptides useful as blockers of calcium channels | Sep 28, 1989 | Issued |
Array
(
[id] => 2775554
[patent_doc_number] => 05132401
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-07-21
[patent_title] => 'MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary'
[patent_app_type] => 1
[patent_app_number] => 7/409434
[patent_app_country] => US
[patent_app_date] => 1989-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 8935
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/132/05132401.pdf
[firstpage_image] =>[orig_patent_app_number] => 409434
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/409434 | MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary | Sep 18, 1989 | Issued |
| 07/395482 | NOVEL INHIBITORS OF THROMBIN | Aug 17, 1989 | Abandoned |
Array
(
[id] => 2946807
[patent_doc_number] => 05180712
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-01-19
[patent_title] => 'Petide antidementia and nootropic agents'
[patent_app_type] => 1
[patent_app_number] => 7/393572
[patent_app_country] => US
[patent_app_date] => 1989-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6221
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/180/05180712.pdf
[firstpage_image] =>[orig_patent_app_number] => 393572
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/393572 | Petide antidementia and nootropic agents | Aug 13, 1989 | Issued |
Array
(
[id] => 2846717
[patent_doc_number] => 05110798
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-05-05
[patent_title] => 'Purine derivatives having pharmacological action'
[patent_app_type] => 1
[patent_app_number] => 7/397457
[patent_app_country] => US
[patent_app_date] => 1989-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2413
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/110/05110798.pdf
[firstpage_image] =>[orig_patent_app_number] => 397457
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/397457 | Purine derivatives having pharmacological action | Aug 9, 1989 | Issued |
Array
(
[id] => 2897699
[patent_doc_number] => 05245013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-09-14
[patent_title] => 'Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides'
[patent_app_type] => 1
[patent_app_number] => 7/367454
[patent_app_country] => US
[patent_app_date] => 1989-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 32
[patent_no_of_words] => 22138
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/245/05245013.pdf
[firstpage_image] =>[orig_patent_app_number] => 367454
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/367454 | Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides | Jun 15, 1989 | Issued |
Array
(
[id] => 2808042
[patent_doc_number] => 05115099
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-05-19
[patent_title] => 'Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates'
[patent_app_type] => 1
[patent_app_number] => 7/365418
[patent_app_country] => US
[patent_app_date] => 1989-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7810
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/115/05115099.pdf
[firstpage_image] =>[orig_patent_app_number] => 365418
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/365418 | Substrates for determination of enzyme activity and intermediates for synthesis of the substrates as well as process for producing the intermediates | Jun 12, 1989 | Issued |
Array
(
[id] => 2948682
[patent_doc_number] => 05180809
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-01-19
[patent_title] => 'Adhesion receptor for laminin and its use'
[patent_app_type] => 1
[patent_app_number] => 7/357354
[patent_app_country] => US
[patent_app_date] => 1989-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 7153
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/180/05180809.pdf
[firstpage_image] =>[orig_patent_app_number] => 357354
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/357354 | Adhesion receptor for laminin and its use | May 24, 1989 | Issued |
| 07/333531 | METHOD FOR CHARACTERIZING POLYMER MOLECULES OR THE LIKE | Apr 4, 1989 | Abandoned |